Mariner LLC Sells 81,553 Shares of Danaher Corporation $DHR

Mariner LLC trimmed its stake in shares of Danaher Corporation (NYSE:DHR) by 19.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 340,058 shares of the conglomerate’s stock after selling 81,553 shares during the quarter. Mariner LLC’s holdings in Danaher were worth $77,860,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. JPL Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter valued at $26,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the third quarter valued at $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the fourth quarter valued at $27,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Wells Fargo & Company lowered their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Royal Bank Of Canada initiated coverage on Danaher in a research report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price on the stock. Finally, JPMorgan Chase & Co. reduced their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Stock Up 0.5%

Shares of NYSE:DHR opened at $181.04 on Tuesday. The business’s 50 day moving average is $180.73 and its 200 day moving average is $204.27. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market cap of $128.13 billion, a P/E ratio of 35.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.